WallStSmart

BTCS Inc (BTCS)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 13144246% more annual revenue ($2.17T vs $16.49M). NMR leads profitability with a 16.7% profit margin vs -202.2%. NMR earns a higher WallStSmart Score of 70/100 (B-).

BTCS

Avoid

30

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 1/9Altman Z: 0.81

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTCS2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
205.3%10/10

Revenue surging 205.3% year-over-year

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

BTCS4 concerns · Avg: 2.5/10
Market CapQuality
$69.93M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Return on EquityProfitability
-118.2%2/10

ROE of -118.2% — below average capital efficiency

EPS GrowthGrowth
-69.6%2/10

Earnings declined 69.6%

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BTCS

The strongest argument for BTCS centers on Price/Book, Revenue Growth. Revenue growth of 205.3% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : BTCS

The primary concerns for BTCS are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

BTCS profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

BTCS carries more volatility with a beta of 3.48 — expect wider price swings.

BTCS is growing revenue faster at 205.3% — sustainability is the question.

BTCS generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 30/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BTCS Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

BTCS Inc. focuses on blockchain technologies and digital currency ecosystems. The company is headquartered in Silver Spring, Maryland.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?